Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H13N3O2 |
Molecular Weight | 207.2291 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(CCCC(=O)C1=CN=CC=C1)N=O
InChI
InChIKey=FLAQQSHRLBFIEZ-UHFFFAOYSA-N
InChI=1S/C10H13N3O2/c1-13(12-15)7-3-5-10(14)9-4-2-6-11-8-9/h2,4,6,8H,3,5,7H2,1H3
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/24830349
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24830349
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or nicotine-derived nitrosamine ketone (NNK) is a tobacco-specific nitrosamine. NNK is considered to be a carcinogen. NNK induces deleterious mutations in oncogenes and tumor suppression genes by forming DNA adducts, which could be considered as tumor initiation. Meanwhile, the binding of NNK to the nicotinic acetylcholine receptor promotes tumor growth by enhancing and deregulating cell proliferation, survival, migration, and invasion, thereby creating a microenvironment for tumor growth.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1907589 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26441658 |
16.7 µM [EC50] | ||
Target ID: CHEMBL2311221 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24830349 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) has been tested for carcinogenicity by various routes of administration in adult mice, rats, and Syrian hamsters, and in limited experiments in mink and ferrets.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28427494
V79 cells were induced with different concentrations of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) (0.1-0.4 mg/mL), and the expression levels of six Prx genes (Prx1-Prx6) were measured by qRT-PCR 24 h following NNK treatment.
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
64091-91-4
Created by
admin on Fri Dec 15 17:19:24 GMT 2023 , Edited by admin on Fri Dec 15 17:19:24 GMT 2023
|
PRIMARY | |||
|
47289
Created by
admin on Fri Dec 15 17:19:24 GMT 2023 , Edited by admin on Fri Dec 15 17:19:24 GMT 2023
|
PRIMARY | |||
|
32692
Created by
admin on Fri Dec 15 17:19:24 GMT 2023 , Edited by admin on Fri Dec 15 17:19:24 GMT 2023
|
PRIMARY | |||
|
7771
Created by
admin on Fri Dec 15 17:19:24 GMT 2023 , Edited by admin on Fri Dec 15 17:19:24 GMT 2023
|
PRIMARY | |||
|
DTXSID3020881
Created by
admin on Fri Dec 15 17:19:24 GMT 2023 , Edited by admin on Fri Dec 15 17:19:24 GMT 2023
|
PRIMARY | |||
|
7S395EDO61
Created by
admin on Fri Dec 15 17:19:24 GMT 2023 , Edited by admin on Fri Dec 15 17:19:24 GMT 2023
|
PRIMARY | |||
|
NNK
Created by
admin on Fri Dec 15 17:19:24 GMT 2023 , Edited by admin on Fri Dec 15 17:19:24 GMT 2023
|
PRIMARY |
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE LESS ACTIVE (PARENT)
METABOLITE REACTIVE TYPE (PARENT)
METABOLITE TOXIC (PARENT)
METABOLITE TOXIC (PARENT)
METABOLITE TOXIC (PARENT)
SUBSTANCE RECORD